Voxelotor Neurocognitive Function Study

Clinical trial NCT05228834 · TERMINATED

Trial details

NCT number: NCT05228834
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2022-06-24
Primary completion: 2022-09-30
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.